HXN-1022

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameHXN-1022
Drug Alias NameHXN-1022
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor ligand superfamily member 4 modulatorsInterleukin-31 modulators
TargetsTumor necrosis factor ligand superfamily member 4Interleukin-31
Therapy Area/IndicationsInflammationAutoimmune DiseasesDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesHelixon Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHelixon LtdEarendil Labs
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A